Applied Biosciences Corp.
APPB
$0.00
$0.000.00%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Revenue | 169.60K | 244.30K | 211.50K | 234.60K | 413.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 169.60K | 244.30K | 211.50K | 234.60K | 413.10K |
| Cost of Revenue | 51.30K | 98.40K | 99.80K | 82.00K | 379.60K |
| Gross Profit | 118.20K | 145.90K | 111.70K | 152.50K | 33.50K |
| SG&A Expenses | 1.05M | 927.00K | 553.70K | 522.10K | 1.42M |
| Depreciation & Amortization | 40.80K | 39.70K | 39.70K | 39.80K | 300.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.14M | 1.07M | 693.20K | 643.90K | 1.80M |
| Operating Income | -970.20K | -820.80K | -481.80K | -409.40K | -1.39M |
| Income Before Tax | -1.43M | -855.20K | -507.90K | -272.00K | -1.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.43M | -855.20K | -507.90K | -272.00K | -1.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 72.50K | 77.50K | 84.00K | 40.30K | -200.00 |
| Net Income | -1.35M | -777.70K | -423.90K | -231.60K | -1.89M |
| EBIT | -970.20K | -820.80K | -481.80K | -409.40K | -1.39M |
| EBITDA | -929.00K | -781.10K | -442.00K | -369.60K | -1.38M |
| EPS Basic | -0.10 | -0.06 | -0.03 | -0.02 | -0.16 |
| Normalized Basic EPS | -0.05 | -0.03 | -0.02 | -0.01 | -0.10 |
| EPS Diluted | -0.10 | -0.06 | -0.03 | -0.02 | -0.16 |
| Normalized Diluted EPS | -0.05 | -0.03 | -0.02 | -0.01 | -0.10 |
| Average Basic Shares Outstanding | 13.65M | 13.47M | 13.81M | 14.21M | 11.80M |
| Average Diluted Shares Outstanding | 13.65M | 13.47M | 13.81M | 14.21M | 11.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
